These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33468471)

  • 41. Prevalence study on carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolates in Czech hospitals--results from Czech Part of European Survey on Carbapenemase--Producing Enterobacteriaceae (EuSCAPE).
    Hrabák J; Študentová V; Jakubů V; Adámková V; Dvořáková L; Balejova M; Bergerová T; Chmelařová E; Ježek P; Kabelíková P; Kolář M; Paterová P; Tejkalová R; Papagiannitsis C; Žemličková H
    Epidemiol Mikrobiol Imunol; 2015 Jun; 64(2):87-91. PubMed ID: 26099612
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro activity of the next-generation aminoglycoside plazomicin alone and in combination with colistin, meropenem, fosfomycin or tigecycline against carbapenemase-producing Enterobacteriaceae strains.
    Rodríguez-Avial I; Pena I; Picazo JJ; Rodríguez-Avial C; Culebras E
    Int J Antimicrob Agents; 2015 Dec; 46(6):616-21. PubMed ID: 26391381
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro and in vivo Effect of Antimicrobial Agent Combinations Against Carbapenem-Resistant
    Liu E; Jia P; Li X; Zhou M; Kudinha T; Wu C; Xu Y; Yang Q
    Infect Drug Resist; 2021; 14():917-928. PubMed ID: 33707959
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A sensitive and specific phenotypic assay for detection of metallo-β-lactamases and KPC in Klebsiella pneumoniae with the use of meropenem disks supplemented with aminophenylboronic acid, dipicolinic acid and cloxacillin.
    Giske CG; Gezelius L; Samuelsen Ø; Warner M; Sundsfjord A; Woodford N
    Clin Microbiol Infect; 2011 Apr; 17(4):552-6. PubMed ID: 20597925
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro evaluation of double carbapenem and colistin combinations against OXA-48, NDM carbapenemase-producing colistin-resistant Klebsiella pneumoniae strains.
    Erdem F; Abulaila A; Aktas Z; Oncul O
    Antimicrob Resist Infect Control; 2020 May; 9(1):70. PubMed ID: 32430058
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence and Molecular Characteristics of Carbapenemase-Producing Enterobacteriaceae From Five Hospitals in Korea.
    Jeong SH; Kim HS; Kim JS; Shin DH; Kim HS; Park MJ; Shin S; Hong JS; Lee SS; Song W
    Ann Lab Med; 2016 Nov; 36(6):529-35. PubMed ID: 27578505
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Distribution of β-lactamase genes among carbapenem-resistant Klebsiella pneumoniae strains isolated from patients in Turkey.
    Iraz M; Özad Düzgün A; Sandallı C; Doymaz MZ; Akkoyunlu Y; Saral A; Peleg AY; Özgümüş OB; Beriş FŞ; Karaoğlu H; Çopur Çiçek A
    Ann Lab Med; 2015 Nov; 35(6):595-601. PubMed ID: 26354347
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of Antimicrobial Effects of a New Polymyxin Molecule (SPR741) When Tested in Combination with a Series of β-Lactam Agents Against a Challenge Set of Gram-Negative Pathogens.
    Mendes RE; Rhomberg PR; Lister T; Cotroneo N; Rubio A; Flamm RK
    Microb Drug Resist; 2020 Apr; 26(4):319-328. PubMed ID: 31596663
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Susceptibilities of ESBL-producing Enterobacteriaceae to ertapenem, meropenem and piperacillin-tazobactam with and without clavulanic acid.
    Raveh D; Yinnon AM; Broide E; Rudensky B
    Chemotherapy; 2007; 53(3):185-9. PubMed ID: 17347564
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro activity of imipenem-relebactam against non-MBL carbapenemase-producing Klebsiella pneumoniae isolated in Greek hospitals in 2015-2016.
    Galani I; Souli M; Nafplioti K; Adamou P; Karaiskos I; Giamarellou H; Antoniadou A;
    Eur J Clin Microbiol Infect Dis; 2019 Jun; 38(6):1143-1150. PubMed ID: 30825054
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of KPC Variant and Porin Genotype on the
    Wilson WR; Kline EG; Jones CE; Morder KT; Mettus RT; Doi Y; Nguyen MH; Clancy CJ; Shields RK
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30617090
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Meropenem-Vaborbactam Tested against Contemporary Gram-Negative Isolates Collected Worldwide during 2014, Including Carbapenem-Resistant, KPC-Producing, Multidrug-Resistant, and Extensively Drug-Resistant Enterobacteriaceae.
    Castanheira M; Huband MD; Mendes RE; Flamm RK
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28652234
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Continuous infusion of meropenem-vaborbactam for a KPC-3-producing Klebsiella pneumoniae bloodstream infection in a critically ill patient with augmented renal clearance.
    Larcher R; Laffont-Lozes P; Naciri T; Bourgeois PM; Gandon C; Magnan C; Pantel A; Sotto A
    Infection; 2023 Dec; 51(6):1835-1840. PubMed ID: 37277691
    [TBL] [Abstract][Full Text] [Related]  

  • 54.
    Huang D; Yu B; Diep JK; Sharma R; Dudley M; Monteiro J; Kaye KS; Pogue JM; Abboud CS; Rao GG
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28438930
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of Modified Hodge Test as a Non-molecular Assay for Accurate Detection of KPC-producing
    Ghasemnejad A; Doudi M; Amirmozafari N
    Pol J Microbiol; 2018; 67(3):291-295. PubMed ID: 30451445
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association Between Minimum Inhibitory Concentration, Beta-lactamase Genes and Mortality for Patients Treated With Piperacillin/Tazobactam or Meropenem From the MERINO Study.
    Henderson A; Paterson DL; Chatfield MD; Tambyah PA; Lye DC; De PP; Lin RTP; Chew KL; Yin M; Lee TH; Yilmaz M; Cakmak R; Alenazi TH; Arabi YM; Falcone M; Bassetti M; Righi E; Rogers BA; Kanj SS; Bhally H; Iredell J; Mendelson M; Boyles TH; Looke DFM; Runnegar NJ; Miyakis S; Walls G; Khamis MAI; Zikri A; Crowe A; Ingram PR; Daneman N; Griffin P; Athan E; Roberts L; Beatson SA; Peleg AY; Cottrell K; Bauer MJ; Tan E; Chaw K; Nimmo GR; Harris-Brown T; Harris PNA;
    Clin Infect Dis; 2021 Dec; 73(11):e3842-e3850. PubMed ID: 33106863
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence and Antibiotic Resistance of Carbapenemase-Producing Gram-Negative Bacteria in Saint Petersburg and Some Other Regions of the Russian Federation.
    Lazareva IV; Ageevets VA; Ershova TA; Zueva LP; Goncharov AE; Darina MG; Svetlichnaya YS; Uskov AN; Sidorenko SV
    Antibiot Khimioter; 2016; 61(11-12):28-38. PubMed ID: 29558058
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro synergy and postantibiotic effect of colistin combinations with meropenem and vancomycin against Enterobacteriaceae with multiple carbapenem resistance mechanisms.
    Bedenić B; Car H; Slačanac D; Sviben M; Čačić M; Lukić-Grlić A; Benčić A; Šijak D; Tripković M; Beader N
    J Infect Chemother; 2018 Dec; 24(12):1016-1019. PubMed ID: 30006247
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Frequency Determination of Carbapenem-Resistant Klebsiella Pneumoniae (CRKP) Isolated from hospitals in Isfahan of Iran and Evaluation of Synergistic Effect of Colistin and Meropenem on them.
    Gheitani L; Fazeli H; Moghim S; Nasr Isfahani B
    Cell Mol Biol (Noisy-le-grand); 2018 Jan; 64(1):70-74. PubMed ID: 29412797
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The use of SWATH to analyse the dynamic changes of bacterial proteome of carbapanemase-producing Escherichia coli under antibiotic pressure.
    Sidjabat HE; Gien J; Kvaskoff D; Ashman K; Vaswani K; Reed S; McGeary RP; Paterson DL; Bordin A; Schenk G
    Sci Rep; 2018 Mar; 8(1):3871. PubMed ID: 29497067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.